Hepatology

Cover image for Vol. 62 Issue 3

Accepted Articles (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.)

Edited By: Michael H. Nathanson

Impact Factor: 11.055

ISI Journal Citation Reports © Ranking: 2014: 5/76 (Gastroenterology & Hepatology)

Online ISSN: 1527-3350

Associated Title(s): Clinical Liver Disease, Liver Transplantation

VIEW

  1. 1 - 73
  1. Correspondence

    1. HIV and Liver Disease: An Update

      Kenneth E. Sherman, Juergen Rockstroh and David Thomas

      Accepted manuscript online: 4 SEP 2015 11:01AM EST | DOI: 10.1002/hep.28150

  2. Liver Failure, Cirrhosis and Portal Hypertension

    1. Prognosis of acute variceal bleeding: is being on beta-blockers an aggravating factor? A short-term survival analysis

      Andrea Ribeiro de Souza, Vincenzo La Mura, Annalisa Berzigotti, Juan Carlos García-Pagán, Juan G Abraldes and Jaime Bosch

      Accepted manuscript online: 4 SEP 2015 10:43AM EST | DOI: 10.1002/hep.28151

  3. Hepatobiliary Malignancies

    1. The MAPK Kinase Kinase 4 Deficiency in Intrahepatic Cholangiocarcinoma Leads to Invasive Growth and Epithelial-Mesenchymal Transition

      Liu-Xiao Yang, Qiang Gao, Jie-Yi Shi, Zhi-Chao Wang, Yong Zhang, Ping-Ting Gao, Xiao-Ying Wang, Ying-Hong Shi, Ai-Wu Ke, Guo-Ming Shi, Jia-Bin Cai, Wei-Ren Liu, Meng Duan, Ying-Jun Zhao, Yuan Ji, Dong-Mei Gao, Kai Zhu, Jian Zhou, Shuang-Jian Qiu, Ya Cao, Qi-Qun Tang and Jia Fan

      Accepted manuscript online: 4 SEP 2015 10:33AM EST | DOI: 10.1002/hep.28149

  4. Liver Failure, Cirrhosis and Portal Hypertension

    1. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy. A randomized controlled trial

      Lesley De Pietri, Marcello Bianchini, Roberto Montalti, Nicola De Maria, Tommaso Di Maira, Bruno Begliomini, Giorgio Enrico Gerunda, Fabrizio di Benedetto, Guadalupe Garcia-Tsao and Erica Villa

      Accepted manuscript online: 4 SEP 2015 10:33AM EST | DOI: 10.1002/hep.28148

  5. Other

    1. Validated and Potential Novel Targets to Treat Hepatitis B Virus

      Fabien Zoulim and Barbara Testoni

      Accepted manuscript online: 4 SEP 2015 10:33AM EST | DOI: 10.1002/hep.28144

  6. Steatohepatitis and Metabolic Liver Disease

    1. LRH-1 and transmethylation fluxes in non-alcoholic steatohepatitis

      José M. Mato and Shelly C. Lu

      Accepted manuscript online: 3 SEP 2015 06:31PM EST | DOI: 10.1002/hep.28146

  7. Correspondence

    1. Reply

      Kai Markus Schneider, Veerle Bieghs, Oliver Pabst and Christian Trautwein

      Accepted manuscript online: 3 SEP 2015 06:30PM EST | DOI: 10.1002/hep.28145

    2. Critical roles of CX3CR1+ mononuclear phagocytes in maintaining gut–liver axis health

      Zongxin Ling, Yiwen Cheng and Lanjuan Li

      Accepted manuscript online: 3 SEP 2015 06:30PM EST | DOI: 10.1002/hep.28147

  8. Steatohepatitis and Metabolic Liver Disease

  9. Viral Hepatitis

    1. Impaired monocyte - macrophage functions and defective tlr signalling in hepatitis e virus infected pregnant women with acute liver failure

      Rashi Sehgal, Sharda Patra, Paul David, Ashish Vyas, Arshi Khanam, Syed Hissar, Ekta Gupta, Guresh Kumar, Shyam Kottilil, Rakhi Maiwall, Shiv Kumar Sarin and Nirupama Trehanpati

      Accepted manuscript online: 31 AUG 2015 06:49PM EST | DOI: 10.1002/hep.28143

  10. Correspondence

    1. Selection criteria for resection in hepatocellular carcinoma: Can we expand them?

      Simona Onali, Francesco Figorilli, James O'Beirne and Martha Sauchuk

      Accepted manuscript online: 28 AUG 2015 05:43PM EST | DOI: 10.1002/hep.28141

    2. HEP-15-1079: The new HCV bottleneck: can delaying therapy be justified Reply to Letter to the Editor (LTE)

      Tracey G. Simon and Raymond T. Chung

      Accepted manuscript online: 27 AUG 2015 06:46PM EST | DOI: 10.1002/hep.28136

  11. Viral Hepatitis

    1. Could gut microbiota protect against sclerosing cholangitis?

      Hanns-Ulrich Marschall and Fredrik Bäckhed

      Accepted manuscript online: 27 AUG 2015 06:45PM EST | DOI: 10.1002/hep.28135

    2. Hepatitis B and D Viral Receptors

      Jisu Li and Jack Wands

      Accepted manuscript online: 27 AUG 2015 06:45PM EST | DOI: 10.1002/hep.28131

    3. Hypoglycemia in a diabetic patient during hepatitis C therapy

      Vicente Soriano, Pablo Barreiro and Carmen de Mendoza

      Accepted manuscript online: 27 AUG 2015 06:43PM EST | DOI: 10.1002/hep.28137

  12. Steatohepatitis and Metabolic Liver Disease

    1. Physical activity and liver diseases

      Annalisa Berzigotti, Uttara Saran and Jean-François Dufour

      Accepted manuscript online: 27 AUG 2015 06:37PM EST | DOI: 10.1002/hep.28132

  13. Hepatology Elsewhere

    1. Cirrhosis and dysbiosis: New insights from next generation sequencing

      James D. Gorham and Michael W Gleeson

      Accepted manuscript online: 27 AUG 2015 06:35PM EST | DOI: 10.1002/hep.28133

  14. Liver Biology and Pathobiology

    1. Dissecting the role of the Epidermal Growth Factor Receptor catalytic activity during liver regeneration and hepatocarcinogenesis

      Judit López-Luque, Daniel Caballero-Díaz, Adoración Martinez-Palacián, César Roncero, Joaquim Moreno-Càceres, María García-Bravo, Esther Grueso, Almudena Fernández, Eva Crosas-Molist, María García-Álvaro, Annalisa Addante, Esther Bertran, Angela M. Valverde, Águeda González-Rodríguez, Blanca Herrera, Lluis Montoliu, Teresa Serrano, Jose-Carlos Segovia, Margarita Fernández, Emilio Ramos, Aránzazu Sánchez and Isabel Fabregat

      Accepted manuscript online: 27 AUG 2015 06:29PM EST | DOI: 10.1002/hep.28134

  15. Autoimmune, Cholestatic and Biliary Disease

    1. Post-Translational Regulation of Polycystin-2 Protein Expression as a Novel Mechanism of Cholangiocyte Reaction and Repair from Biliary Damage

      Carlo Spirli, Ambra Villani, Valeria Mariotti, Luca Fabris, Romina Fiorotto and Mario Strazzabosco

      Accepted manuscript online: 27 AUG 2015 06:26PM EST | DOI: 10.1002/hep.28138

  16. Viral Hepatitis

    1. Breaking the species barrier for hepatitis delta virus

      Benjamin Y. Winer and Alexander Ploss

      Accepted manuscript online: 20 AUG 2015 02:10AM EST | DOI: 10.1002/hep.28129

  17. Autoimmune, Cholestatic and Biliary Disease

    1. Risk Stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists

      Palak J. Trivedi, Christophe Corpechot, Albert Pares and Gideon M. Hirschfield

      Accepted manuscript online: 20 AUG 2015 02:10AM EST | DOI: 10.1002/hep.28128

  18. Liver Biology and Pathobiology

    1. Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through p110δ-dependent induction and expansion of Tregs in mice

      Forough Khadem, Xiaoling Gao, Zhirong Mou, Ping Jia, Hesamaldin Movassagh, Chukwunonso Onyilagha, Abdelilah S. Gounni, Matthew C. Wright and Jude E. Uzonna

      Accepted manuscript online: 20 AUG 2015 02:09AM EST | DOI: 10.1002/hep.28130

  19. Viral Hepatitis

    1. CETP: A Kupffer cell marker linking hepatic inflammation with atherogenic dyslipidemia?

      Joel T. Haas and Bart Staels

      Accepted manuscript online: 17 AUG 2015 06:43PM EST | DOI: 10.1002/hep.28125

  20. Steatohepatitis and Metabolic Liver Disease

    1. Association of Non-alcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States from 2004-2009

      Zobair M. Younossi, Munkhzul Otgonsuren, Linda Henry, Chapy Venkatesan, Alita Mishra, Madeline Erario and Sharon Hunt

      Accepted manuscript online: 14 AUG 2015 01:22PM EST | DOI: 10.1002/hep.28123

    2. LRH-1 is a critical determinant of methyl-pool metabolism

      Martin Wagner, Sungwoo Choi, Katrin Panzitt, Jennifer L. Mamrosh, Jae Man Lee, Alex Zaufel, Rui Xiao, Ruth Wooton-Kee, Marcus Ståhlman, Christopher B. Newgard, Jan Borén and David D. Moore

      Accepted manuscript online: 12 AUG 2015 06:07PM EST | DOI: 10.1002/hep.28124

  21. Viral Hepatitis

    1. Research is needed on the difficult-to-cure population of HCV patients with disability

      Viktor Viktorov Chirikov, Fadia Shaya, C. Daniel Mullins, Susan dosReis, Eberechukwu Onukwugha and Charles D. Howell

      Accepted manuscript online: 11 AUG 2015 07:28PM EST | DOI: 10.1002/hep.28120

  22. Autoimmune, Cholestatic and Biliary Disease

    1. Natural killer cells regulate T cell immune responses in primary biliary cirrhosis

      Shinji Shimoda, Satomi Hisamoto, Kenichi Harada, Sho Iwasaka, Yong Chong, Minoru Nakamura, Yuki Bekki, Tomoharu Yoshizumi, Ken Shirabe, Toru Ikegami, Yoshihiko Maehara, Xiao-Song He, M. Eric Gershwin and Koichi Akashi

      Accepted manuscript online: 11 AUG 2015 07:27PM EST | DOI: 10.1002/hep.28122

  23. Clinical Observations in Hepatology

    1. Fecal microbiota transplantation (FMT) in the management of hepatic encephalopathy (HE)

      Dina Kao, Brandi Roach, Heekuk Park, Naomi Hotte, Karen Madsen, Vince Bain and Puneeta Tandon

      Accepted manuscript online: 11 AUG 2015 07:27PM EST | DOI: 10.1002/hep.28121

  24. Viral Hepatitis

    1. Diabetes and Prediabetes in Patients with Hepatitis B Residing in North America

      Mandana Khalili, Manuel Lombardero, Raymond T Chung, Norah A Terrault, Marc G Ghany, W. Ray Kim, Daryl Lau, Mauricio Lisker-Melman, Arun Sanyal, Anna S Lok and for the HBRNThe HBRN: Minnesota Alliance for Research in Chronic Hepatitis B Consortium

      Accepted manuscript online: 8 AUG 2015 10:19AM EST | DOI: 10.1002/hep.28110

  25. Hepatobiliary Malignancies

    1. Sorafenib enriches EpCAM positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade

      Dong-Xian Guan, Jie Shi, Yang Zhang, Jiang-Sha Zhao, Ling-Yun Long, Tian-Wei Chen, Er-Bin Zhang, Yuan-Yuan Feng, Wen-Dai Bao, Yue-Zhen Deng, Lin Qiu, Xue-Li Zhang, H. Phillip Koeffler, Jing-Jing Li, Shuqun Cheng and Dong Xie

      Accepted manuscript online: 7 AUG 2015 06:08PM EST | DOI: 10.1002/hep.28117

  26. Autoimmune, Cholestatic and Biliary Disease

    1. High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires

      Evaggelia Liaskou, Eva Kristine Klemsdal Henriksen, Kristian Holm, Fatemeh Kaveh, David Hamm, Janine Fear, Marte K Viken, Johannes Roksund Hov, Espen Melum, Harlan Robins, Johanna Olweus, Tom H Karlsen and Gideon M Hirschfield

      Accepted manuscript online: 7 AUG 2015 06:07PM EST | DOI: 10.1002/hep.28116

  27. Viral Hepatitis

    1. Hepatoma in hepatitis B – Infectious disease or Liver disease?

      David K. Wong

      Accepted manuscript online: 7 AUG 2015 06:06PM EST | DOI: 10.1002/hep.28118

  28. Liver Injury and Regeneration

    1. Hepatic stellate cells relay inflammation signaling from sinusoids to parenchyma in mouse models of immune-mediated hepatitis

      Tomoko Fujita, Kitipong Soontrapa, Yoshiya Ito, Keiko Iwaisako, Catharina Sagita Moniaga, Masataka Asagiri, Masataka Majima and Shuh Narumiya

      Accepted manuscript online: 6 AUG 2015 06:43PM EST | DOI: 10.1002/hep.28112

  29. Hepatobiliary Malignancies

    1. Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy

      Kyu Sik Jung, Seung Up Kim, Kijun Song, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim and Kwang-Hyub Han

      Accepted manuscript online: 6 AUG 2015 06:41PM EST | DOI: 10.1002/hep.28115

  30. Correspondence

    1. Reply to the Letter Entitled “Severe Hepatotoxicity Associated with Asunaprevir and Daclatasvir in Chronic Hepatitis C”

      Yohei Fujii, Yoshihito Uchida and Satoshi Mochida

      Accepted manuscript online: 6 AUG 2015 06:40PM EST | DOI: 10.1002/hep.28114

  31. Viral Hepatitis

    1. Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1

      Paula M. Perin, Sibylle Haid, Richard J. P. Brown, Juliane Doerrbecker, Kai Schulze, Carsten Zeilinger, Markus von Schaewen, Brigitte Heller, Koen Vercauteren, Eva Luxenburger, Yasmine M. Baktash, Florian W. R. Vondran, Sietkse Speerstra, Abdullah Awadh, Furkat Mukhtarov, Luis M Schang, Andreas Kirschning, Rolf Müller, Carlos A. Guzman, Lars Kaderali, Glenn Randall, Philip Meuleman, Alexander Ploss and Thomas Pietschmann

      Accepted manuscript online: 6 AUG 2015 06:40PM EST | DOI: 10.1002/hep.28111

    2. Antibodies to an interfering epitope in hepatitis C Virus E2 can mask vaccine-induced neutralizing activity

      Alla Kachko, Sharon E. Frey, Lev Sirota, Ranjit Ray, Frances Wells, Iryna Zubkova, Pei Zhang and Marian E. Major

      Accepted manuscript online: 6 AUG 2015 06:40PM EST | DOI: 10.1002/hep.28108

    3. Severe hepatotoxicity associated with asunaprevir and daclatasvir in chronic hepatitis C

      Soichiro Shibata, Takeji Umemura, Michiharu Komatsu and Eiji Tanaka

      Accepted manuscript online: 6 AUG 2015 06:39PM EST | DOI: 10.1002/hep.28113

    4. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households – national health and nutrition examination survey (NHANES), 1988-2012

      Henry Roberts, Deanna Kruszon-Moran, Kathleen N. Ly, Elizabeth Hughes, Kashif Iqbal, Ruth B. Jiles and Scott D. Holmberg

      Accepted manuscript online: 6 AUG 2015 06:39PM EST | DOI: 10.1002/hep.28109

    5. Acetaminophen knocks on deaths door and RIP1 kinase answers

      Maria Eugenia Guicciardi, Gregory J. Gores and Hartmut Jaeschke

      Accepted manuscript online: 6 AUG 2015 06:38PM EST | DOI: 10.1002/hep.28107

    6. A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance

      Hui Wang, Souhayla El Maadidi, Janett Fischer, Elena Grabski, Sabine Dickhöfer, Sascha Klimosch, Sinead M. Flannery, Angela Filomena, Olaf-Oliver Wolz, Nicole Schneiderhan-Marra, Markus W. Löffler, Manfred Wiese, Tica Pichulik, Beat Müllhaupt, David Semela, Jean-François Dufour, the East-German and Swiss Hepatitis C Virus Study Groups, Pierre-Yves Bochud, Andrew G. Bowie, Ulrich Kalinke, Thomas Berg and Alexander N. R. Weber

      Accepted manuscript online: 6 AUG 2015 10:36AM EST | DOI: 10.1002/hep.28105

  32. Steatohepatitis and Metabolic Liver Disease

    1. Genetic Susceptibility to HEV Infection – An Enigmatic Virus Gives Up a Secret

      Ivo Ditah and Michael Charlton

      Accepted manuscript online: 6 AUG 2015 10:24AM EST | DOI: 10.1002/hep.28106

  33. Correspondence

    1. Reply: Does the death knell toll for phlebotomy in NAFLD?

      LA Adams, DH Crawford, TG St.Pierre and JK Olynyk

      Accepted manuscript online: 3 AUG 2015 06:31PM EST | DOI: 10.1002/hep.28030

    2. Does the death knell toll for phlebotomy in NAFLD?

      JD Ryan, T Marjot and JF Cobbold

      Accepted manuscript online: 3 AUG 2015 06:31PM EST | DOI: 10.1002/hep.28029

  34. Viral Hepatitis

    1. Present and future therapies of hepatitis B: From discovery to cure

      T. Jake Liang, Timothy M. Block, Brian J. McMahon, Marc G. Ghany, Stephan Urban, Ju-Tao Guo, Stephen Locarnini, Fabien Zoulim, Kyong-Mi Chang and Anna S. Lok

      Accepted manuscript online: 3 AUG 2015 06:02PM EST | DOI: 10.1002/hep.28025

    2. You have full text access to this OnlineOpen article
      Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States

      Robert G. Gish, Chari A. Cohen, Joan M. Block, Carol L. Brosgart, Timothy M. Block, Ryan Clary, Loc T. Le, Michael H. Ninburg, Lorren Sandt and Kris V. Kowdley

      Accepted manuscript online: 3 AUG 2015 06:02PM EST | DOI: 10.1002/hep.28026

  35. Hepatology Elsewhere

    1. Repurposing an old drug: A low-cost allergy medication provides new hope for hepatitis C patients

      Charles Rice and Zhilei Chen

      Accepted manuscript online: 3 AUG 2015 06:02PM EST | DOI: 10.1002/hep.28028

  36. Liver Failure, Cirrhosis and Portal Hypertension

    1. The prognostic value of HVPG in patients with cirrhosis is highly dependent on the accuracy of the technique

      Gilberto Silva-Junior, Anna Baiges, Fanny Turon, Ferran Torres, Virginia Hernández-Gea, Jaime Bosch and Juan Carlos García-Pagán

      Accepted manuscript online: 3 AUG 2015 06:00PM EST | DOI: 10.1002/hep.28031

  37. Viral Hepatitis

    1. HCV vertical transmission in pregnancy: New horizons in the era of DAAs

      Tomi T Kanninen, Douglas Dieterich and Stefania Asciutti

      Accepted manuscript online: 3 AUG 2015 05:59PM EST | DOI: 10.1002/hep.28032

  38. Hepatobiliary Malignancies

    1. Fibroblast growth factor receptor 3 isoforms: novel therapeutic targets for hepatocellular carcinoma?

      Jakob Paur, Lisa Nika, Christiane Maier, Alexander Moscu-Gregor, Julia Kostka, Daniela Huber, Thomas Mohr, Petra Heffeter, Waltraud C. Schrottmaier, Sonja Kappel, Daniela Kandioler, Klaus Holzmann, Brigitte Marian, Walter Berger, Michael Grusch and Bettina Grasl-Kraupp

      Accepted manuscript online: 1 AUG 2015 11:03AM EST | DOI: 10.1002/hep.28023

  39. Liver Biology and Pathobiology

    1. Jagged1 heterozygosity in mice results in a congenital cholangiopathy which is reversed by concomitant deletion of one copy of Poglut1 (Rumi)

      Shakeel M. Thakurdas, Mario F. Lopez, Shinako Kakuda, Rodrigo Fernandez-Valdivia, Neda Zarrin-Khameh, Robert S. Haltiwanger and Hamed Jafar-Nejad

      Accepted manuscript online: 1 AUG 2015 11:02AM EST | DOI: 10.1002/hep.28024

  40. Autoimmune, Cholestatic and Biliary Disease

    1. The UK-PBC Risk Scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cirrhosis

      M Carbone, S.J. Sharp, S Flack, D Paximadas, K Spiess, C Adgey, L Griffiths, R Lim, P Trembling, K.D. Williamson, UK-PBC Consortium, N.J. Wareham, M Aldersley, A Bathgate, A.K. Burroughs, M.A. Heneghan, J.M. Neuberger, D Thorburn, G.M. Hirschfield, H.J. Cordell, G.J. Alexander, D.E.J. Jones, R.N. Sandford and G.F. Mells

      Accepted manuscript online: 29 JUL 2015 07:51PM EST | DOI: 10.1002/hep.28017

  41. Liver Failure, Cirrhosis and Portal Hypertension

    1. Aspartate Aminotransferase to Platelet Ratio and Fibrosis-4 as Biomarkers in Biopsy Validated Pediatric Cystic Fibrosis Liver Disease

      Daniel H. Leung, Mahjabeen Khan, Charles G. Minard, Danielle Guffey, Louise E. Ramm, Andrew D. Clouston, Gregory Miller, Peter J. Lewindon, Ross W. Shepherd and Grant A. Ramm

      Accepted manuscript online: 29 JUL 2015 07:51PM EST | DOI: 10.1002/hep.28016

  42. Viral Hepatitis

    1. Randomized Controlled Trial of Entecavir Versus Placebo in Children with HBeAg-positive Chronic Hepatitis B

      Maureen M. Jonas, Mei-Hwei Chang, Etienne Sokal, Kathleen B. Schwarz, Deirdre Kelly, Kyung Mo Kim, Simon C. Ling, Philip Rosenthal, Dumitru Oraseanu, Laurie Reynolds, Alexandra Thiry and Peter Ackerman

      Accepted manuscript online: 29 JUL 2015 07:49PM EST | DOI: 10.1002/hep.28015

  43. Steatohepatitis and Metabolic Liver Disease

    1. Quantitative MR Imaging of Hepatic Steatosis: Validation in Ex Vivo Human Livers

      Peter Bannas, Harald Kramer, Diego Hernando, Rashmi Agni, Ashley M. Cunningham, Rakesh Mandal, Utaroh Motosugi, Samir D. Sharma, Alejandro Munoz del Rio, Luis Fernandez and Scott B. Reeder

      Accepted manuscript online: 29 JUL 2015 07:45PM EST | DOI: 10.1002/hep.28012

  44. Viral Hepatitis

    1. A targeted functional RNAi screen uncovers Glypican 5 as an entry factor for hepatitis B and D viruses

      Eloi R. Verrier, Che C. Colpitts, Charlotte Bach, Laura Heydmann, Amélie Weiss, Mickaël Renaud, Sarah C. Durand, François Habersetzer, David Durantel, Georges Abou-Jaoudé, Maria M. López Ledesma, Daniel J. Felmlee, Magali Soumillon, Tom Croonenborghs, Nathalie Pochet, Michael Nassal, Catherine Schuster, Laurent Brino, Camille Sureau, Mirjam B. Zeisel and Thomas F. Baumert

      Accepted manuscript online: 29 JUL 2015 07:45PM EST | DOI: 10.1002/hep.28013

  45. Autoimmune, Cholestatic and Biliary Disease

    1. B cells expressing CD11b effectively inhibit CD4+ T cell responses and ameliorate experimental autoimmune hepatitis

      Xiaoming Liu, Xuechao Jiang, Ronghua Liu, Luman Wang, Tingting Qian, Yijie Zheng, Yuting Deng, Enyu Huang, Fengkai Xu and Yiwei Chu

      Accepted manuscript online: 24 JUL 2015 03:58AM EST | DOI: 10.1002/hep.28001

  46. Steatohepatitis and Metabolic Liver Disease

    1. The fat droplet in hepatocellular ballooning and implications for scoring NASH therapeutic response

      Curtis K Argo, Yoshihiro Ikura, Carolin Lackner and Stephen H Caldwell

      Accepted manuscript online: 23 JUL 2015 06:34PM EST | DOI: 10.1002/hep.28009

  47. Correspondence

    1. Immunonutrition in Patients undergoing Liver Transplantation- Too Premature to Draw Conclusions

      Shishira Bharadwaj, John M Rivas, Andrea Jevenn, Ibrahim Hanouneh and Ezra Steiger

      Accepted manuscript online: 23 JUL 2015 06:23PM EST | DOI: 10.1002/hep.28004

  48. Steatohepatitis and Metabolic Liver Disease

    1. Implication of low vitamin D status in sarcopenia and non-alcoholic fatty liver disease

      Ho Cheol Hong and Kyung Mook Choi

      Accepted manuscript online: 23 JUL 2015 06:22PM EST | DOI: 10.1002/hep.28008

  49. Correspondence

    1. Sarcopenia and nonalcoholic fatty liver disease: new evidence for low vitamin D status contributing to the link

      Qing Pang, Kai Qu, Chang Liu, Jing– Yao Zhang and Su-Shun Liu

      Accepted manuscript online: 23 JUL 2015 06:22PM EST | DOI: 10.1002/hep.28010

    2. Reply to comments

      Cynthia D Guy and Anna Mae Diehl

      Accepted manuscript online: 23 JUL 2015 06:21PM EST | DOI: 10.1002/hep.28011

  50. Liver Injury and Regeneration

    1. Imaging the Dynamic Platelet-Neutrophil Response in Sterile Liver Injury and Repair in Mice

      Ingrid Slaba, Jing Wang, Elzbieta Kolaczkowska, Braedon McDonald, Woo-Yong Lee and Paul Kubes

      Accepted manuscript online: 22 JUL 2015 06:08PM EST | DOI: 10.1002/hep.28003

  51. Steatohepatitis and Metabolic Liver Disease

    1. Comparative effectiveness of pharmacological interventions for non-alcoholic steatohepatitis: A systematic review and network meta-analysis

      Siddharth Singh, Rohan Khera, Alina M. Allen, M. Hassan Murad and Rohit Loomba

      Accepted manuscript online: 18 JUL 2015 03:23AM EST | DOI: 10.1002/hep.27999

  52. Correction

    1. You have free access to this content
      This article corrects: Serotonin in liver tumor: Friend or foe?

      Qing Pang

      Accepted manuscript online: 16 JUL 2015 06:14PM EST | DOI: 10.1002/hep.27997

      This article corrects:

      Serotonin in liver tumor: Friend or foe?

      Vol. 62, Issue 1, 319, Article first published online: 6 MAY 2015

  53. Retraction

    1. Retraction: Steatohepatitis as impaired immune metabolism induced by liver resident regulatory T-cell depletion

      Yutaka Shimazu, Masahide Hamaguchi, Takuya Fukuda, Kanji Yamaguchi, Yoshio Sumida, Tatsuaki Tsuruyama, Tim Sparwasser, Akifumi Takaori-Kondo, Michiaki Fukui, Yoshito Itoh and Naoto Nakamura

      Accepted manuscript online: 14 JUL 2015 09:46AM EST | DOI: 10.1002/hep.27986

  54. Liver Injury and Regeneration

    1. Presence of Diabetes Mellitus and Steatosis is Associated with Liver Stiffness in a General Population : The Rotterdam Study

      Edith M. Koehler, Elisabeth P.C. Plompen, Jeoffrey N.L. Schouten, Bettina E. Hansen, Sarwa Darwish Murad, Pavel Taimr, Frank W.G. Leebeek, Albert Hofman, Bruno H. Stricker, Laurent Castera and Harry L.A. Janssen

      Accepted manuscript online: 14 JUL 2015 08:54AM EST | DOI: 10.1002/hep.27981

  55. Hepatobiliary Malignancies

    1. You have full text access to this OnlineOpen article
      Worldwide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma

      Catherine de Martel, Delphine Maucort-Boulch, Martyn Plummer and Silvia Franceschi

      Accepted manuscript online: 3 JUL 2015 06:59PM EST | DOI: 10.1002/hep.27969

  56. Steatohepatitis and Metabolic Liver Disease

  57. Viral Hepatitis

    1. A Clinician's Guide to Drug-Drug Interactions with Direct Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection

      Travis B. Dick, Lance S. Lindberg, Debra D. Ramirez and Michael R. Charlton

      Accepted manuscript online: 29 MAY 2015 11:25AM EST | DOI: 10.1002/hep.27920

    2. Retracted: HLA-A2-/HLA-DR1-transgeneic H-2 class I-/class II-knockout mouse is an ideal animal model for study of chronic HBV infection

      Ding-Qiang Chen, Ling Yang, Jie Zhou, Liwei Lu, Yu-Chun Lone, Kwok-Yung Yuen and Bo-Jian Zheng

      Accepted manuscript online: 23 AUG 2010 11:36AM EST | DOI: 10.1002/hep.23932

VIEW

  1. 1 - 73

SEARCH

SEARCH BY CITATION